253 results on '"Qvortrup, Camilla"'
Search Results
2. TRIFLURIDINE/TIPIRACIL (FTD/TPI) with or without bevacizumab in previously treated patients with esophago-gastric adenocarcinoma, a randomised phase III trial
3. The effect of BRAFV600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer – A post-hoc exploratory analysis of the randomized NORDIC9-study
4. ctDNA for Risk of Recurrence Assessment in Patients Treated with Neoadjuvant Treatment: A Systematic Review and Meta-analysis
5. Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy – The randomized NORDIC9-study
6. Neoadjuvant treatment of colorectal cancer: comprehensive review
7. A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study
8. Chemotherapy and Targeted Drugs for Patients with Metastatic Colorectal Cancer
9. Immunotherapy in Patients with mCRC
10. Adjuvant Therapy in Patients with Colorectal Cancer
11. Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study.
12. Introduction to Oncology
13. Temporal trends and regional variability in BRAF and KRAS genetic testing in Denmark (2010–2022): Implications for precision medicine.
14. ASO Visual Abstract: ctDNA for Recurrence Risk Assessment in Patients Treated with Neoadjuvant Treatment—A Systematic Review and Meta-analysis
15. TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial
16. Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial
17. Introduction to Oncology
18. Chemotherapy and Targeted Drugs for Patients with Metastatic Colorectal Cancer
19. Adjuvant Therapy in Patients with Colorectal Cancer
20. Immunotherapy in Patients with mCRC
21. Evolution of surgical approach to rectal cancer resection: A multinational registry assessment.
22. Impact of adjuvant chemotherapy on long-term overall survival in patients with high-risk stage II colon cancer: a nationwide cohort study
23. The effect of BRAFV600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer – A post-hoc exploratory analysis of the randomized NORDIC9-study
24. Loss Of Hemoglobin Mass Is Associated With Decreased Aerobic Capacity After Chemotherapy For Gastroesophageal Cancer
25. Global cancer control: responding to the growing burden, rising costs and inequalities in access
26. Evaluating the efficacy and safety of neoadjuvant pembrolizumab in patients with stage I–III MMR-deficient colon cancer: a national, multicentre, prospective, single-arm, phase II study protocol
27. Abstract CT096: Phase 1 study of RO7119929 (TLR7 agonist prodrug) in patients (pts) with advanced primary or metastatic liver cancers
28. Abstract 2342: RO7119929, a TLR7 agonist prodrug, induces local inflammation of the tumor microenvironment (TME) by reprogramming myeloid cells in patients (pts) with advanced primary or metastatic liver cancers
29. Systemic Therapy for Patients with Colorectal Cancer: State of the Art
30. Therapy with pembrolizumab in treatment‐naïve patients with nonmetastatic, mismatch repair deficient colorectal cancer
31. Can we predict toxicity and efficacy in older patients with cancer? Older patients with colorectal cancer as an example
32. Extensive genomic analysis in patients with KRAS-mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact
33. Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: prevalence and correlation betweenDPYD-genotype variants and P-uracil concentrations
34. The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study
35. DPYD genotyping and dihydropyrimidine dehydrogenase (DPD) phenotyping in clinical oncology. A clinically focused minireview
36. Abstract 3254: Multiomics detect potential mechanisms of resistance to BRAF targeted therapy in patients with BRAFV600E mutated solid tumors
37. KRASG12C inhibition in colorectal cancer
38. Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: prevalence and correlation between DPYD-genotype variants and P-uracil concentrations.
39. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
40. Oxaliplatin Neuropathy: Predictive Values of Skin Biopsy, QST and Nerve Conduction
41. Colorectal cancer screening in Europe: what are the next steps?
42. Maintenance Therapy With Cetuximab Every Second Week in the First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-7.5 Study by the Nordic Colorectal Cancer Biomodulation Group
43. 2021 ESMO World GI NORDIC9
44. Systemic Therapy for Patients with Colorectal Cancer: State of the Art
45. Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study
46. New use for old drugs: Epirubicin in colorectal cancer
47. Angiogenesis Inhibitors for Colorectal Cancer. A Review of the Clinical Data
48. How to select cancer patients for immunotherapy
49. Anti-EGFR Treatment in Patients with Colorectal Cancer
50. High expression of microRNA-625–3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.